Why the study?
Does the degree of pulmonary vasodilatation during short-term prostacyclin infusion predict survival in patients with primary pulmonary hypertension?
Does the degree of pulmonary vasodilatation during short-term prostacyclin infusion predict survival in patients with primary pulmonary hypertension?
Patients with primary pulmonary hypertension who exhibit a >50% decrease in total pulmonary resistance index during short-term prostacyclin challenge have a significantly better 2-year survival rate.
No takes yet. Share an insight, caveat, or question.
Acute vasodilator response may aid prognostication; leaves open whether it should guide therapy selection.
Raffy et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: